This past June 1st, the FDA approved Prolia ™ (denosumab), a brand new twice-yearly injectable osteoporosis drug by Amgen. The first drug of its kind, Prolia was designed to treat and prevent postmenopausal osteoporosis for patients considered to be at high risk of fractures. It's also marketed as an alternative treatment for those who have failed or are intolerant to … Click to continue →
Get started with your free eBook.
Discover the top 14 things you’re doing that are damaging your bones.